<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03024372</url>
  </required_header>
  <id_info>
    <org_study_id>Sutures vs Clips AVF</org_study_id>
    <nct_id>NCT03024372</nct_id>
  </id_info>
  <brief_title>Continuous Suturing Versus Interrupted Clips for Brachiocephalic AV Fistula Creation</brief_title>
  <official_title>A Prospective Randomized Single Blinded Study of Continuous Suturing Versus Interrupted Clips for Brachiocephalic AV Fistula Creation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of South Florida</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of South Florida</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>No</is_unapproved_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate a promising strategy to improve maturation and
      patency rates following creation of AV fistulas and assess whether an anastomosis performed
      with Anastoclips (interrupted, nonpenetrating) would produce better maturation and/or patency
      than one performed with conventional suturing techniques.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This will be a single blind (patient and dialysis center), prospective, randomized trial
      conducted at a single center. The study intervention will be randomization between
      conventional sutured anastomosis (Control group) and use of Anastoclips (Treatment group),
      which provide an interrupted closure without intimal penetration.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">December 2017</start_date>
  <completion_date type="Anticipated">August 2024</completion_date>
  <primary_completion_date type="Anticipated">February 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time to loss of primary patency</measure>
    <time_frame>one year post surgery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to loss of secondary patency</measure>
    <time_frame>one year post surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to loss of assisted primary patency</measure>
    <time_frame>one year post surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of functional maturation</measure>
    <time_frame>one year post surgery</time_frame>
    <description>in patients on dialysis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to functional maturation</measure>
    <time_frame>one year post surgery</time_frame>
    <description>in patients on dialysis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of assumed maturation</measure>
    <time_frame>one year post surgery</time_frame>
    <description>in patients not on dialysis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to assumed maturation</measure>
    <time_frame>one year post surgery</time_frame>
    <description>in patients not on dialysis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of complications</measure>
    <time_frame>30 days post surgery</time_frame>
    <description>thrombosis/thrombectomy, stenosis, skin erosion, limb swelling, steal syndrome, bleeding and hematoma formation at surgical site, surgical-site-related infection, access-related infection, rupture, revision</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of intervention</measure>
    <time_frame>five years post surgery</time_frame>
    <description>to maintain patency</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Operative cost</measure>
    <time_frame>duration of surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall cost</measure>
    <time_frame>time of surgery to time of hospital discharge (can range from 1 day to 1 week or more)</time_frame>
    <description>Overall cost of surgery itself defined as from surgery to point of hospital discharge, anticipated to be in days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to loss of primary patency</measure>
    <time_frame>5 years post surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to loss of assisted primary patency</measure>
    <time_frame>5 years post surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to loss of secondary patency</measure>
    <time_frame>5 years post surgery</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">164</enrollment>
  <condition>Arteriovenous Fistula</condition>
  <arm_group>
    <arm_group_label>Conventional sutures</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>AV fistula creation with sutures</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Anastoclips</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>AV fistula creation with clips</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>AV Fistula creation with sutures</intervention_name>
    <description>End-to-side anastomosis (of AV fistula) is to be constructed using sutures. The incision is to be irrigated and closed using Vicryl, Biosyn and skin glue.</description>
    <arm_group_label>Conventional sutures</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>AV Fistula creation with clips</intervention_name>
    <description>End-to-side anastomosis (of AV fistula) is to be constructed using clips. The incision is to be irrigated and closed using Vicryl, Biosyn and skin glue.</description>
    <arm_group_label>Anastoclips</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Requiring brachiocephalic fistula judged to be best option for access after vein
             mapping (Surgeons will be required to do 10 cases using Anastoclips prior to
             enrolling)

          -  Able to provide informed consent in English or Spanish

          -  Age 18 years or greater

          -  With estimated life expectancy of 2 years or more

          -  Able to comply with study procedures including all scheduled follow-up visits

        Exclusion Criteria:

          -  Unable to provide informed consent in English or Spanish

          -  Age &lt; 18 years

          -  With pacemaker, IACD, or other permanent obstructive device on that side (a temporary
             tunneled dialysis catheter is not an exclusion)

          -  Unable (or in surgeon's judgment a poor risk) to comply with study procedures and
             follow-up visits

          -  With estimated life expectancy of less than 2 years

          -  Females must be either:

               -  Of non-childbearing potential, which is defined as post-menopausal (at least 12
                  months without menses prior to Treatment Day) or documented surgically sterile or
                  post hysterectomy (at least 1 month prior to Treatment Day)

               -  Or, of childbearing potential, in which case must have a negative urine pregnancy
                  test at Treatment Day
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Karl Illig, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of South Florida</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Thanh Tran, MPH</last_name>
    <phone>813-844-8544</phone>
    <email>thanhtran@health.usf.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Rachel Karlnoski, PhD</last_name>
    <phone>813-844-4133</phone>
    <email>rkarlnos@health.usf.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Tampa General Hospital</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33606</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rachel Karlnoski, PhD</last_name>
      <phone>813-844-4133</phone>
      <email>rkarlnos@health.usf.edu</email>
    </contact>
    <contact_backup>
      <last_name>Thanh Tran, MPH</last_name>
      <phone>8138448544</phone>
      <email>thanhtran@health.usf.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Karl Illig, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Aurelia Calero, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of South Florida - South Tampa Campus</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33606</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rachel Karlnoski, PhD</last_name>
      <phone>813-844-4133</phone>
      <email>rkarlnos@health.usf.edu</email>
    </contact>
    <contact_backup>
      <last_name>Thanh Tran, MPH</last_name>
      <phone>8138448544</phone>
      <email>thanhtran@health.usf.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Karl Illig, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Aurelia Calero, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>USF Health Carol and Frank Morsani Center for Advanced Healthcare</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33612</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rachel Karlnoski, PhD</last_name>
      <phone>813-844-4133</phone>
      <email>rkarlnos@health.usf.edu</email>
    </contact>
    <contact_backup>
      <last_name>Thanh Tran, MPH</last_name>
      <phone>8138448544</phone>
      <email>thanhtran@health.usf.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Karl Illig, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Aurelia Calero, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.usrds.org</url>
    <description>US Renal Data System</description>
  </link>
  <reference>
    <citation>Haruguchi H, Nakagawa Y, Uchida Y, Sageshima J, Fuchinoue S, Agishi T. Clinical application of vascular closure staple clips for blood access surgery. ASAIO J. 1998 Sep-Oct;44(5):M562-4.</citation>
    <PMID>9804495</PMID>
  </reference>
  <reference>
    <citation>Schild AF, Pruett CS, Newman MI, Raines J, Petersen F, Konkin T, Kim P, Dickson C, Kirsch WM. The utility of the VCS clip for creation of vascular access for hemodialysis: long-term results and intraoperative benefits. Cardiovasc Surg. 2001 Dec;9(6):526-30.</citation>
    <PMID>11604333</PMID>
  </reference>
  <reference>
    <citation>Cook JW, Schuman ES, Standage BA, Heinl P. Patency and flow characteristics using stapled vascular anastomoses in dialysis grafts. Am J Surg. 2001 Jan;181(1):24-7.</citation>
    <PMID>11248171</PMID>
  </reference>
  <reference>
    <citation>Cooper BZ, Flores L, Ramirez JA, Najjar JG, Abir F, Rayham R, Paladino L, Nguyen M, Panetta TF. Analysis of nonpenetrating clips versus sutures for arterial venous graft anastomosis. Ann Vasc Surg. 2001 Jan;15(1):7-12.</citation>
    <PMID>11221948</PMID>
  </reference>
  <reference>
    <citation>Zeebregts CJ. Randomized clinical trial of continuous sutures or non-penetrating clips for radiocephalic arteriovenous fistula (Br J Surg 2004; 91: 1438-1442). Br J Surg. 2005 May;92(5):654-5.</citation>
    <PMID>15852413</PMID>
  </reference>
  <reference>
    <citation>Sukhatme VP. Vascular access stenosis: prospects for prevention and therapy. Kidney Int. 1996 Apr;49(4):1161-74. Review.</citation>
    <PMID>8691738</PMID>
  </reference>
  <reference>
    <citation>Suresh K. An overview of randomization techniques: An unbiased assessment of outcome in clinical research. J Hum Reprod Sci. 2011 Jan;4(1):8-11. doi: 10.4103/0974-1208.82352.</citation>
    <PMID>21772732</PMID>
  </reference>
  <reference>
    <citation>Sidawy AN, Gray R, Besarab A, Henry M, Ascher E, Silva M Jr, Miller A, Scher L, Trerotola S, Gregory RT, Rutherford RB, Kent KC. Recommended standards for reports dealing with arteriovenous hemodialysis accesses. J Vasc Surg. 2002 Mar;35(3):603-10. Review.</citation>
    <PMID>11877717</PMID>
  </reference>
  <reference>
    <citation>Zhou XH, Melfi CA, Hui SL. Methods for comparison of cost data. Ann Intern Med. 1997 Oct 15;127(8 Pt 2):752-6.</citation>
    <PMID>9382393</PMID>
  </reference>
  <results_reference>
    <citation>Shenoy S, Miller A, Petersen F, Kirsch WM, Konkin T, Kim P, Dickson C, Schild AF, Stewart L, Reyes M, Anton L, Woodward RS. A multicenter study of permanent hemodialysis access patency: beneficial effect of clipped vascular anastomotic technique. J Vasc Surg. 2003 Aug;38(2):229-35.</citation>
    <PMID>12891102</PMID>
  </results_reference>
  <results_reference>
    <citation>Nguyen KP, Teruya T, Alabi O, Sheng N, Bianchi C, Chiriano J, Dehom S, Abou-Zamzam A. Comparison of Nonpenetrating Titanium Clips versus Continuous Polypropylene Suture in Dialysis Access Creation. Ann Vasc Surg. 2016 Apr;32:15-9. doi: 10.1016/j.avsg.2015.11.008. Epub 2016 Jan 22.</citation>
    <PMID>26806237</PMID>
  </results_reference>
  <results_reference>
    <citation>Aitken E, Jeans E, Aitken M, Kingsmore D. A randomized controlled trial of interrupted versus continuous suturing techniques for radiocephalic fistulas. J Vasc Surg. 2015 Dec;62(6):1575-82. doi: 10.1016/j.jvs.2015.07.083. Epub 2015 Oct 23. Erratum in: J Vasc Surg. 2016 Apr;63(4):1133.</citation>
    <PMID>26506936</PMID>
  </results_reference>
  <results_reference>
    <citation>Zeebregts C, van den Dungen J, Buikema H, van der Want J, van Schilfgaarde R. Preservation of endothelial integrity and function in experimental vascular anastomosis with non-penetrating clips. Br J Surg. 2001 Sep;88(9):1201-8.</citation>
    <PMID>11531868</PMID>
  </results_reference>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 6, 2017</study_first_submitted>
  <study_first_submitted_qc>January 17, 2017</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 18, 2017</study_first_posted>
  <last_update_submitted>October 24, 2017</last_update_submitted>
  <last_update_submitted_qc>October 24, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 26, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fistula</mesh_term>
    <mesh_term>Arteriovenous Fistula</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

